| Name | (5-methyl-1,3,4-oxadiazol-2-yl)methanamine |
|---|---|
| Synonyms |
5-methyl-1,3,4-oxadiazole-2-methanamine
1,3,4-OXADIAZOLE-2-METHANAMINE,5-METHYL C-(5-methyl[1,3,4]oxadiazol-2-yl)methylamine (5-Methyl-1,3,4-oxadiazol-2-yl)methanamine (5-methyl-1,3,4-oxadiazol-2-yl)methylamine |
| Density | 1.192g/cm3 |
|---|---|
| Boiling Point | 223.048ºC at 760 mmHg |
| Molecular Formula | C4H7N3O |
| Molecular Weight | 113.11800 |
| Flash Point | 88.697ºC |
| Exact Mass | 113.05900 |
| PSA | 64.94000 |
| LogP | 0.53700 |
| Vapour Pressure | 0.098mmHg at 25°C |
| Index of Refraction | 1.502 |
| Hazard Codes | Xi: Irritant; |
|---|---|
| HS Code | 2934999090 |
|
~34%
125295-22-9 |
| Literature: Bristol-Myers Squibb Company Patent: US2008/4265 A1, 2008 ; Location in patent: Page/Page column 34 ; |
| Precursor 1 | |
|---|---|
| DownStream 0 | |
| HS Code | 2934999090 |
|---|---|
| Summary | 2934999090. other heterocyclic compounds. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |